C
Chiral Pharmacology
Definition: Chiral pharmacology is the branch of pharmacology that studies how molecular chirality influences the pharmacological behavior of drugs. It examines the stereoselective differences between enantiomers in terms of pharmacodynamics, pharmacokinetics, metabolism, therapeutic efficacy, toxicity, and clinical outcomes.
Context: Most biological macromolecules-including receptors, enzymes, ion channels, transport proteins, and nucleic acids-are inherently chiral. Consequently, individual enantiomers of a chiral drug often interact differently with these biological targets, leading to distinct pharmacological and toxicological profiles. Chiral pharmacology provides the scientific basis for understanding these stereoselective interactions and supports the rational design, development, regulatory evaluation, and clinical use of single-enantiomer drugs.
Example: Esomeprazole, the (S)-enantiomer of omeprazole, exhibits improved pharmacokinetic properties and more consistent acid suppression than the racemic formulation. Likewise, levobupivacaine demonstrates reduced cardiotoxicity compared with racemic bupivacaine, illustrating the clinical significance of chiral pharmacology.
Broader Concept: Stereopharmacology
Associated Concept: Chiral Drug
Narrower Concept: Chiral Pharmacodynamics; Chiral Pharmacokinetics
Related Terms: Chirality, Stereochemistry, Enantiomer, Chiral Drug, Stereoselectivity, Chiral Pharmacodynamics, Chiral Pharmacokinetics, Eutomer, Distomer, Chiral Switch.
Reference: Hutt, A. J., & Caldwell, J. (1985). The importance of stereochemistry in drug action and disposition. Pharmacology & Therapeutics, 29(2), 245-263.
Caldwell, J. (1995). Chiral pharmacology and the regulation of new drugs. Chemistry and Industry, 6, 176-179.
Ariens, E. J. (1984). Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. European Journal of Clinical Pharmacology, 26, 663-668.
Agranat, I., Caner, H., & Caldwell, J. (2002). Putting chirality to work: The strategy of chiral switches. Nature Reviews Drug Discovery, 1(10), 753-768.
Nguyen, L. A., He, H., & Pham-Huy, C. (2006). Chiral Drugs: An Overview. International Journal of Biomedical Science, 2(2), 85-100.
Smith, S. W. (2009). Chiral Toxicology: It's the Same Thing... Only Different. Toxicological Sciences, 110(1), 4-30.
S
Stereopharmacology
Broader Concept:
Chromatography
Associated Concept:
Chiral Pharmacology
Narrower Concepts:
Chiral Pharmacology
Definition: Stereopharmacology is the branch of pharmacology that investigates how the three-dimensional stereochemical structure of drug molecules influences their interactions with biological systems. It encompasses the effects of all forms of stereoisomerism-including chirality, geometric isomerism, atropisomerism, conformational isomerism, and other stereochemical features-on pharmacodynamics, pharmacokinetics, metabolism, toxicity, and therapeutic efficacy.
Context: Biological targets such as receptors, enzymes, ion channels, transport proteins, and nucleic acids are inherently three-dimensional and stereospecific. Consequently, differences in the stereochemistry of drug molecules can profoundly affect binding affinity, intrinsic activity, selectivity, absorption, distribution, metabolism, excretion, and toxicity. Stereopharmacology provides the conceptual framework for understanding these stereoselective interactions and plays a central role in modern drug discovery, medicinal chemistry, regulatory science, and precision therapeutics. Chiral pharmacology represents one of its most important sub-disciplines.
Example: The cis and trans isomers of tamoxifen exhibit different biological activities, while the (R)- and (S)-enantiomers of drugs such as ibuprofen and propranolol differ in pharmacological potency and disposition. These examples illustrate how stereochemistry, in its various forms, influences drug action.
Related Terms: Pharmacology, Chirality, Stereochemistry, Chiral Pharmacology, Enantiomer, Diastereomer, Geometric Isomerism, Atropisomerism, Conformational Isomerism, Stereoselectivity, Chiral Drug.
Reference: Hutt, A. J., & Caldwell, J. (1985). The importance of stereochemistry in drug action and disposition. Pharmacology & Therapeutics, 29(2), 245-263.
Ariens, E. J. (1984). Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. European Journal of Clinical Pharmacology, 26, 663-668.
Caldwell, J. (1995). Chiral pharmacology and the regulation of new drugs. Chemistry and Industry, 6, 176-179.
Jamali, F., Mehvar, R., & Pasutto, F. M. (1994). Enantioselective Aspects of Drug Action and Disposition. Wiley.
Agranat, I., Caner, H., & Caldwell, J. (2002). Putting chirality to work: The strategy of chiral switches. Nature Reviews Drug Discovery, 1(10), 753-768.
Nguyen, L. A., He, H., & Pham-Huy, C. (2006). Chiral Drugs: An Overview. International Journal of Biomedical Science, 2(2), 85-100.
Smith, S. W. (2009). Chiral Toxicology: It's the Same Thing... Only Different. Toxicological Sciences, 110(1), 4-30.
Key Distinction (recommended for Chiralpedia)
Although the two terms are sometimes used interchangeably, stereopharmacology is the broader discipline, encompassing the influence of all forms of stereochemistry on drug action and disposition. Chiral pharmacology is a specialized branch that focuses specifically on the pharmacological consequences of molecular chirality and enantiomerism.
